Clariant celebrated the completion of its newly expanded state-of-the-art facilities at Daya Bay, China which significantly enhances the company’s manufacturing capabilities in pharmaceutical excipients and specialty chemicals for personal and home care applications.

This strategic CHF 80-million investment reflects Clariant's commitment to meeting growing demand in the Chinese market while strengthening its position as a leading supplier of high-quality specialty chemicals in Asia.

Clariant celebrated its Care Chemicals expansion at Daya Bay, strengthening its position in China.

“This expansion not only increases our production capacity but also enhances our ability to collaborate closely with local customers on tailored solutions. We're now better equipped than ever to support the innovation needs of our Chinese customers across the pharmaceutical, personal care, and home care sectors,” said Christian Vang, Business President Care Chemicals at Clariant.

The pharmaceutical capabilities expansion includes a second spray tower specifically designed to serve customers in south China. This enhancement has positioned Clariant as a key supplier for both Active Pharmaceutical Ingredients (APIs) in laxatives and pharmaceutical excipients throughout China.

With over 30 years of experience manufacturing polyethylene glycols (PEGs), Clariant has significantly expanded its Polyglykol capacity at the Daya Bay site. The healthcare product portfolio includes essential ingredients such as VitiPure, Polyglykol, Lanogen, and Motusflex, which function as solubilizers, emulsifiers, and solvents in pharmaceutical formulations. The Polyglykol brand also encompasses APIs used in laxative formulations and ophthalmic medicines.

Complementing the pharmaceutical expansion, Clariant has also expanded their multi-purpose plant (MPP) at Daya Bay with an additional reactor. This facility is dedicated to producing specialty chemicals, including mild surfactants for the beauty industry and soil release polymers for the home care sector under the Texcare range.

Clariant's Daya Bay expansion features high-performance surfactants, including water-based coatings formulations that reduce VOC emissions and synthetic lubricant ingredients that extend equipment life. In addition, the company offers efficient crop protection additives for precision agriculture and soil health series enhancers that improve water and nutrient retention.

The expansion has also significantly increased Clariant's production capacity for Ethylene Oxide Derivatives (EODs) and a broader chemical portfolio at Daya Bay.

Clariant celebrated the completion of its newly expanded state-of-the-art facilities at Daya Bay, China which significantly enhances the company’s manufacturing capabilities in pharmaceutical excipients and specialty chemicals for personal and home care applications.

This strategic CHF 80-million investment reflects Clariant's commitment to meeting growing demand in the Chinese market while strengthening its position as a leading supplier of high-quality specialty chemicals in Asia.

Clariant celebrated its Care Chemicals expansion at Daya Bay, strengthening its position in China.

“This expansion not only increases our production capacity but also enhances our ability to collaborate closely with local customers on tailored solutions. We're now better equipped than ever to support the innovation needs of our Chinese customers across the pharmaceutical, personal care, and home care sectors,” said Christian Vang, Business President Care Chemicals at Clariant.

The pharmaceutical capabilities expansion includes a second spray tower specifically designed to serve customers in south China. This enhancement has positioned Clariant as a key supplier for both Active Pharmaceutical Ingredients (APIs) in laxatives and pharmaceutical excipients throughout China.

With over 30 years of experience manufacturing polyethylene glycols (PEGs), Clariant has significantly expanded its Polyglykol capacity at the Daya Bay site. The healthcare product portfolio includes essential ingredients such as VitiPure, Polyglykol, Lanogen, and Motusflex, which function as solubilizers, emulsifiers, and solvents in pharmaceutical formulations. The Polyglykol brand also encompasses APIs used in laxative formulations and ophthalmic medicines.

Complementing the pharmaceutical expansion, Clariant has also expanded their multi-purpose plant (MPP) at Daya Bay with an additional reactor. This facility is dedicated to producing specialty chemicals, including mild surfactants for the beauty industry and soil release polymers for the home care sector under the Texcare range.

Clariant's Daya Bay expansion features high-performance surfactants, including water-based coatings formulations that reduce VOC emissions and synthetic lubricant ingredients that extend equipment life. In addition, the company offers efficient crop protection additives for precision agriculture and soil health series enhancers that improve water and nutrient retention.

The expansion has also significantly increased Clariant's production capacity for Ethylene Oxide Derivatives (EODs) and a broader chemical portfolio at Daya Bay.